Is AMTM a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on A record backlog that front loads visibility, with revenue (fy2026 guidance) at ~$13.95B to ~$14.3B. The bear case rests on amentum is a government services contractor, so budget outcomes, continuing resolutions, shutdowns and shifting agency priorities flow almost directly into revenue. Analysts covering it are spread from $22.00 to $40.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Amentum is a government services contractor, so budget outcomes, continuing resolutions, shutdowns and shifting agency priorities flow almost directly into revenue. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $22.00, -11.2% from the $24.77 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

A record backlog that front loads visibility. Backlog stood at roughly $47.8 billion in the fiscal second quarter of 2026, more than three times annual revenue, with a book to bill near 1.2x. The most optimistic analyst target on AMTM is $40.00, +61.5% from the $24.77 price. That figure is only reachable if this thesis works close to its best case.

Amentum is a government services contractor, so budget outcomes, continuing resolutions, shutdowns and shifting agency priorities flow almost directly into revenue. Contract concentration matters as well: a single large recompete lost at re bid can remove billions from backlog, and protests can delay awards already booked. Leverage near 3.2x leaves less room for error than a cash rich balance sheet would, and the company pays no dividend, so the equity return case depends on debt paydown and margin execution rather than income. The business also carries the usual government contracting exposures, including audits, False Claims Act and qui tam litigation, and cost disallowances, and Amentum has faced legacy suits inherited from acquired entities. Finally, it is a young public company assembled from two organizations, so integration slippage or a guidance reset would land on a share base with a short trading history to anchor expectations. The most pessimistic published target is $22.00, -11.2% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Government engineering and mission-support services contractor formed from the Jacobs Critical Mission Solutions spin-merger.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (A record backlog that front loads visibility) stalling in the reported numbers rather than in the narrative, the risk above (amentum is a government services contractor, so budget outcomes, continuing resolutions, shutdowns and shifting agency priorities flow almost directly into revenue) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Amentum provides engineering, technology and mission support services to government customers, including nuclear operations and environmental cleanup for the Department of Energy, space and science support for NASA, logistics, base operations and aviation sustainment for the Department of Defense, and cyber, intelligence and critical digital infrastructure work. It reports in two segments, Digital Solutions and Global Engineering Solutions.

Jacobs Solutions separated its Critical Mission Solutions and Cyber & Intelligence businesses and merged them with legacy Amentum in a Reverse Morris Trust transaction that closed on September 27, 2024. Regular way trading on the NYSE under the ticker AMTM began on September 30, 2024. Jacobs shareholders received shares in the combined company as part of the structure.

A Reverse Morris Trust lets a parent company separate a business and merge it with a partner in a way that is generally tax free to the parent and its shareholders, provided the parent's holders end up owning more than half of the combined entity. Jacobs used it to divest Critical Mission Solutions without triggering a large tax bill, and Amentum gained public listing and scale in one step rather than through a conventional IPO.